Prudential Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Buy
449,839
+308,710
+219% +$1.27M ﹤0.01% 1419
2025
Q4
$476K Buy
141,129
+91,194
+183% +$237K ﹤0.01% 1848
2025
Q3
$65.4K Buy
49,935
+29,300
+142% +$30.3K ﹤0.01% 2314
2025
Q2
$14.7K Buy
20,635
+8,854
+75% +$6.95K ﹤0.01% 2411
2025
Q1
$17.3K Sell
11,781
-133,807
-92% -$319K ﹤0.01% 2261
2024
Q4
$645K Sell
145,588
-5,200
-3% -$21.1K ﹤0.01% 1741
2024
Q3
$621K Sell
150,788
-3,150
-2% -$16.9K ﹤0.01% 2122
2024
Q2
$1M Sell
153,938
-2,520
-2% -$17.8K ﹤0.01% 1833
2024
Q1
$1.36M Sell
156,458
-2,077
-1% -$25.2K ﹤0.01% 1669
2023
Q4
$1.81M Sell
158,535
-2,958
-2% -$29.3K ﹤0.01% 1496
2023
Q3
$1.56M Sell
161,493
-11,565
-7% -$113K ﹤0.01% 1522
2023
Q2
$2M Buy
173,058
+42,152
+32% +$453K ﹤0.01% 1409
2023
Q1
$1.51M Sell
130,906
-4,290
-3% -$48.1K ﹤0.01% 1509
2022
Q4
$1.68M Sell
135,196
-1,011
-0.7% -$11.5K ﹤0.01% 1420
2022
Q3
$1.57M Sell
136,207
-20,195
-13% -$229K ﹤0.01% 1485
2022
Q2
$1.88M Buy
156,402
+120,575
+337% +$1.42M ﹤0.01% 1423
2022
Q1
$450K Sell
35,827
-497,102
-93% -$5.7M ﹤0.01% 2248
2021
Q4
$6.21M Sell
532,929
-328,710
-38% -$4.03M 0.01% 916
2021
Q3
$11.3M Buy
861,639
+186,469
+28% +$2.41M 0.02% 694
2021
Q2
$8.69M Buy
675,170
+659,810
+4,296% +$7.55M 0.01% 819
2021
Q1
$172K Buy
15,360
+1,458
+10% +$15.4K ﹤0.01% 2419
2020
Q4
$159K Sell
13,902
-8,330
-37% -$91.2K ﹤0.01% 2373
2020
Q3
$200K Buy
22,232
+8,540
+62% +$84.9K ﹤0.01% 2283
2020
Q2
$141K Buy
13,692
+956
+8% +$9.78K ﹤0.01% 2303
2020
Q1
$129K Buy
12,736
+392
+3% +$4.61K ﹤0.01% 2243
2019
Q4
$164K Sell
12,344
-1,860
-13% -$20.5K ﹤0.01% 2342
2019
Q3
$122K Buy
14,204
+80
+0.6% +$777 ﹤0.01% 2352
2019
Q2
$155K Sell
14,124
-1,259
-8% -$14.1K ﹤0.01% 2370
2019
Q1
$174K Sell
15,383
-1,421
-8% -$15.9K ﹤0.01% 2334
2018
Q4
$146K Sell
16,804
-84
-0.5% -$964 ﹤0.01% 2277
2018
Q3
$261K Sell
16,888
-883
-5% -$14K ﹤0.01% 2244
2018
Q2
$285K Buy
17,771
+608
+4% +$9K ﹤0.01% 2222
2018
Q1
$222K Hold
17,163
﹤0.01% 2234
2017
Q4
$215K Sell
17,163
-226
-1% -$2.95K ﹤0.01% 2245
2017
Q3
$230K Buy
17,389
+155
+0.9% +$2.13K ﹤0.01% 2224
2017
Q2
$273K Sell
17,234
-27,259
-61% -$396K ﹤0.01% 2173
2017
Q1
$636K Sell
44,493
-38,495
-46% -$526K ﹤0.01% 1981
2016
Q4
$1.06M Buy
82,988
+66,984
+419% +$846K ﹤0.01% 1822
2016
Q3
$213K Buy
16,004
+943
+6% +$11K ﹤0.01% 2205
2016
Q2
$165K Buy
15,061
+1,671
+12% +$16.3K ﹤0.01% 2219
2016
Q1
$123K Sell
13,390
-238
-2% -$1.96K ﹤0.01% 2235
2015
Q4
$132K Buy
13,628
+119
+0.9% +$1.15K ﹤0.01% 2181
2015
Q3
$118K Hold
13,509
﹤0.01% 2163
2015
Q2
$136K Buy
13,509
+239
+2% +$2.78K ﹤0.01% 2170
2015
Q1
$178K Sell
13,270
-120
-0.9% -$1.57K ﹤0.01% 2153
2014
Q4
$172K Hold
13,390
﹤0.01% 2123
2014
Q3
$145K Sell
13,390
-12,883
-49% -$147K ﹤0.01% 2151
2014
Q2
$337K Buy
26,273
+13,480
+105% +$147K ﹤0.01% 2150
2014
Q1
$132K Buy
12,793
+836
+7% +$9.4K ﹤0.01% 2200
2013
Q4
$116K Sell
11,957
-597
-5% -$5.36K ﹤0.01% 2228
2013
Q3
$125K Buy
12,554
+239
+2% +$2.35K ﹤0.01% 2207
2013
Q2
$103K Buy
+12,315
New +$149K ﹤0.01% 2218

Other funds holding IRWD

Prudential Financial's IRWD Position: Q1 2026 in Review

Prudential Financial increased its Ironwood Pharmaceuticals (IRWD) stake by 219% in Q1 2026, buying an estimated $1.27M and bringing the position to 449,839 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Prudential Financial first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.3M in Q3 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Prudential Financial held 449,839 shares of Ironwood Pharmaceuticals worth $1.58M as of Q1 2026.
  • Prudential Financial bought 308,710 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.27M.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1419 holding.
  • Prudential Financial first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Prudential Financial's Ironwood Pharmaceuticals position peaked at $11.3M in Q3 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.